Variant report
Variant | esv3387333 |
---|---|
Chromosome Location | chr4:120263598-120264791 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148893841 | chr4:120263621-120263622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs143457155 | chr4:120263622-120263623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
3 | rs538567227 | chr4:120263631-120263632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558168111 | chr4:120263635-120263636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373033527 | chr4:120263834-120263835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534032180 | chr4:120263980-120263981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377404820 | chr4:120264058-120264059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574060156 | chr4:120264089-120264090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541592520 | chr4:120264198-120264199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555165922 | chr4:120264205-120264206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534007682 | chr4:120264246-120264247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs193149612 | chr4:120264256-120264257 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
13 | rs544137677 | chr4:120264278-120264279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200956545 | chr4:120264355-120264356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563919692 | chr4:120264361-120264362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577516977 | chr4:120264366-120264367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs202182769 | chr4:120264409-120264410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200209487 | chr4:120264462-120264463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201333619 | chr4:120264470-120264471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539855008 | chr4:120264556-120264557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375212377 | chr4:120264602-120264603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560157568 | chr4:120264626-120264627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185604900 | chr4:120264652-120264653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28706437 | chr4:120264737-120264738 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
25 | rs28691602 | chr4:120264770-120264771 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs563109102 | chr4:120264785-120264786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120262200-120264600 | Weak transcription | HepG2 | liver |
2 | chr4:120263200-120264000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:120264000-120264400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:120264400-120266400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:120264600-120264800 | Enhancers | HepG2 | liver |